Proteinuria and hypertension.
Ritz E, Nowicki M, Fliser D, Hörner D, Klimm HP.
Kidney Int Suppl. 1994 Nov;47:S76-80.
Nephrosclerosis and hypertension.
Ono H, Ono Y.
Med Clin North Am. 1997 Nov;81(6):1273-88. doi: 10.1016/s0025-7125(05)70582-4.
[Ischemic nephropathy].
Mann J.
Ther Umsch. 1994 Dec;51(12):819-23.
Effect of Proteinuria and Glomerular Filtration Rate on Renal Outcome in Patients with Biopsy-Proven Benign Nephrosclerosis.
Sumida K, Hoshino J, Ueno T, Mise K, Hayami N, Suwabe T, Kawada M, Imafuku A, Hiramatsu R, Hasegawa E, Yamanouchi M, Sawa N, Fujii T, Ohashi K, Takaichi K, Ubara Y.
PLoS One. 2016 Jan 25;11(1):e0147690. doi: 10.1371/journal.pone.0147690. eCollection 2016.
Time-averaged proteinuria during follow-up and renal prognosis in patients with biopsy-proven benign nephrosclerosis.
Amano H, Koike K, Haruhara K, Tsuboi N, Ogura M, Yokoo T.
Clin Exp Nephrol. 2020 Aug;24(8):688-695. doi: 10.1007/s10157-020-01885-w. Epub 2020 Apr 9.
Renal ablation acutely transforms 'benign' hypertension to 'malignant' nephrosclerosis in hypertensive rats.
Bidani AK, Griffin KA, Plott W, Schwartz MM.
Hypertension. 1994 Sep;24(3):309-16. doi: 10.1161/01.hyp.24.3.309.
"Benign" hypertensive nephrosclerosis.
Dasgupta I, Porter C, Innes A, Burden R.
QJM. 2007 Feb;100(2):113-9. doi: 10.1093/qjmed/hcl139. Epub 2007 Jan 23.
[Hypertensive nephrosclerosis].
Krummel T, Bazin D, Faller AL, Hannedouche T.
Presse Med. 2012 Feb;41(2):116-24. doi: 10.1016/j.lpm.2011.04.008. Epub 2011 Jun 8.
Clinical features of benign hypertensive nephrosclerosis at time of renal biopsy.
Innes A, Johnston PA, Morgan AG, Davison AM, Burden RP.
Q J Med. 1993 Apr;86(4):271-5.
Systemic and glomerular hypertension and progression of chronic renal disease: the dilemma of nephrosclerosis.
Marín R, Gorostidi M, Fernández-Vega F, Alvarez-Navascués R.
Kidney Int Suppl. 2005 Dec;(99):S52-6. doi: 10.1111/j.1523-1755.2005.09910.x.
